Balayan M S
Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow, Russia.
J Viral Hepat. 1997 May;4(3):155-65. doi: 10.1046/j.1365-2893.1997.00145.x.
Hepatitis E is an acute, icteric, self-limiting disease, which is spread widely in many tropical and subtropical countries where it occurs both in the form of epidemics of variable magnitude or sporadically. Hepatitis E affects young adults, rather than children, and causes a high mortality rate, particularly in pregnant women. In industrialized countries this disease occurs occasionally as imported sporadic cases. The aetiological cause of hepatitis E is a virus, hepatitis E virus (HEV), which is temporally classified as a member of the Calicivirus family, although its genomic composition is unique. There are experimental data as well as epidemiological observations allowing us to assume that hepatitis E may be a zoonosis as HEV is pathogenic for some domestic and wild animals. Recently, serological assays based on the use of recombinant or synthetic antigens were developed and applied to determine the prevalence of antibody to HEV (anti-HEV) in various epidemic and non-epidemic settings. In suspected hepatitis E cases, anti-HEV seropositivity was detected at an elevated rate but the overall seroprevalence of anti-HEV in normal human populations of endemic areas appeared to be unexpectedly low. A low but constant presence of anti-HEV seropositivity was observed also in non-endemic industrialized countries. In some of these countries, anti-HEV seropositivity was accumulated in groups of patients with various liver and non-liver pathologies and certain groups at risk for blood-borne infections.
戊型肝炎是一种急性、黄疸性、自限性疾病,在许多热带和亚热带国家广泛传播,以规模不等的流行形式或散发形式出现。戊型肝炎主要影响青壮年而非儿童,并且导致高死亡率,尤其是在孕妇中。在工业化国家,这种疾病偶尔以输入性散发病例的形式出现。戊型肝炎的病因是一种病毒,即戊型肝炎病毒(HEV),尽管其基因组组成独特,但在分类学上暂时被归类为杯状病毒科的成员。有实验数据和流行病学观察结果使我们能够假设戊型肝炎可能是人畜共患病,因为HEV对一些家畜和野生动物具有致病性。最近,基于使用重组或合成抗原的血清学检测方法得以开发并应用于确定在各种流行和非流行环境中抗HEV抗体(抗-HEV)的流行率。在疑似戊型肝炎病例中,抗-HEV血清阳性率升高,但在流行地区正常人群中抗-HEV的总体血清流行率似乎出乎意料地低。在非流行的工业化国家也观察到抗-HEV血清阳性率较低但持续存在。在其中一些国家,抗-HEV血清阳性在患有各种肝脏和非肝脏疾病的患者群体以及某些有血源感染风险的群体中有所累积。